who discovered glp 1 agonists Evolution of GLP‐1 Receptor for Diabetes Treatment Who should win a Nobel
Description
Monitoring your biomarkers through regular blood work gives you the data you need to stay motivated
GLP-1R agonists cannot be currently recommended as targeted approaches for MASH but should be administered for their indications (T2D, obesity)
GLP-1
This means researchers face a genuine cost-benefit analysis when choosing their target maintenance dose
Benge explains that pills are far less invasive than an injectable medication
